Clinical trial

Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

NCT02106546

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Carboplatin Normalized identity: carboplatinView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Veliparib Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Paclitaxel Normalized identity: paclitaxelView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo to veliparib Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-04-10

PhasePHASE3

Conditions

Squamous Non-Small Cell Lung Cancerunresolved

Interventions

CarboplatinDRUG · verified · RxNorm: carboplatin

VeliparibDRUG

PaclitaxelDRUG · verified · RxNorm: paclitaxel

Placebo to veliparibDRUG

Sponsors & collaborators

AbbVielead sponsor

Mapped research locations

DallasTexas, United States3 CairoEgypt3 AustinTexas, United States2 IstanbulTurkey (Türkiye)2 QuébecQuebec, Canada2 AthensGreece2 LincolnNebraska, United States2 IzmirTurkey (Türkiye)2 BelgradeSerbia2 Rio de JaneiroBrazil2 PortoPortugal2 RigaLatvia2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02106546 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.